Literature DB >> 29649630

Standard CD44 modulates YAP1 through a positive feedback loop in hepatocellular carcinoma.

Zhenhai Fan1, Hongwei Xia2, Huanji Xu2, Ji Ma3, Sheng Zhou2, Wanting Hou2, Qiulin Tang2, Qiyong Gong4, Yongzhan Nie5, Feng Bi6.   

Abstract

High expression levels of CD44 and YAP have been identified as poor prognostic factors in hepatocellular carcinoma (HCC). However, the mechanistic relationship between CD44 and YAP during HCC tumorigenesis remains largely unknown. To investigate the mutual regulation between standard CD44 (CD44S) and YAP1 in HCC cell lines and tissue samples, CD44S and YAP1 expression in 40 pairs of tumor samples and matched distal normal tissues from HCC patients was examined by immunohistochemical staining. High expression of either CD44S or YAP1 was associated with a younger age and worse pathology grade. In addition, high levels of CD44S and YAP1 were associated with increased vascular invasion and more severe liver cirrhosis, respectively. CD44S expression was positively correlated with YAP1 expression in these HCC tissues. In vitro experiments suggested that CD44S could positively regulate the expression of YAP1 and its target genes via the PI3K/Akt pathway in HCC cells. Moreover, CD44S is regulated by the YAP1/TEAD axis. These results reveal a novel positive feedback loop involving CD44S and YAP1, in which CD44S functions as both an upstream regulator and a downstream effector of YAP1 in HCC. This feedback loop might constitute a broadly conserved module for regulating cell proliferation and invasion during HCC tumorigenesis. Blocking this positive feedback loop that involves CD44S and YAP1 might represent a new approach for HCC treatment.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  CD44; Hepatocellular carcinoma; Hippo signaling pathway; YAP

Mesh:

Substances:

Year:  2018        PMID: 29649630     DOI: 10.1016/j.biopha.2018.03.042

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  Multi-modal imaging for uptake of peptide ligand specific for CD44 by hepatocellular carcinoma.

Authors:  Xiaoli Wu; Xiaoqing Meng; Tse-Shao Chang; Shuo Feng; Miki Lee; Sangeeta Jaiswal; Eun-Young K Choi; Lam Tran; Hui Jiang; Thomas D Wang
Journal:  Photoacoustics       Date:  2022-04-11

2.  Aspirin attenuates YAP and β-catenin expression by promoting β-TrCP to overcome docetaxel and vinorelbine resistance in triple-negative breast cancer.

Authors:  Ji Ma; Zhenhai Fan; Qiulin Tang; Hongwei Xia; Tao Zhang; Feng Bi
Journal:  Cell Death Dis       Date:  2020-07-13       Impact factor: 8.469

3.  CD44 Promotes Migration and Invasion of Docetaxel-Resistant Prostate Cancer Cells Likely via Induction of Hippo-Yap Signaling.

Authors:  Chih-Jen Lai; Ching-Yu Lin; Wen-Ying Liao; Tzyh-Chyuan Hour; Horng-Dar Wang; Chih-Pin Chuu
Journal:  Cells       Date:  2019-03-30       Impact factor: 6.600

4.  The novel interplay between CD44 standard isoform and the caspase-1/IL1B pathway to induce hepatocellular carcinoma progression.

Authors:  Jun Li; Yongwei Zhang; Ran Ruan; Wei He; Yeben Qian
Journal:  Cell Death Dis       Date:  2020-11-09       Impact factor: 8.469

5.  Rhosin Suppressed Tumor Cell Metastasis through Inhibition of Rho/YAP Pathway and Expression of RHAMM and CXCR4 in Melanoma and Breast Cancer Cells.

Authors:  Masanobu Tsubaki; Shuuji Genno; Tomoya Takeda; Takuya Matsuda; Naoto Kimura; Yuuma Yamashita; Yuusuke Morii; Kazunori Shimomura; Shozo Nishida
Journal:  Biomedicines       Date:  2021-01-04

6.  Exosomal CD44 Transmits Lymph Node Metastatic Capacity Between Gastric Cancer Cells via YAP-CPT1A-Mediated FAO Reprogramming.

Authors:  Mei Wang; Wanjun Yu; Xiaoli Cao; Hongbing Gu; Jiaying Huang; Chen Wu; Lin Wang; Xin Sha; Bo Shen; Ting Wang; Yongliang Yao; Wei Zhu; Feng Huang
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

Review 7.  Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway.

Authors:  Geofrey Mahiki Mranda; Zhi-Ping Xiang; Jun-Jian Liu; Tian Wei; Yinlu Ding
Journal:  Front Oncol       Date:  2022-08-12       Impact factor: 5.738

8.  Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis.

Authors:  Miao Fang; Min Yao; Jie Yang; Wen-Jie Zheng; Li Wang; Deng-Fu Yao
Journal:  World J Gastrointest Oncol       Date:  2020-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.